INDEX / DRUCKVERSION / SUCHE / KONTAKT / IMPRESSUM / TERMINANFRAGE ONLINE / RÜCKRUFSERVICE / DOWNLOAD: PRAXISINFO / FAQ
EnglischEnglisch

A- A= A+

EnglischEnglisch
Logo
+49 228 911 50-0
Veröffentlichungen

Veröffentlichungen

Folgende wissenschaftliche Veröffentlichungen wurden zum Thema PET und PET-CT von Prof. Dr. Holger Palmedo, Dr. Holger Brockmann und Dr. Andreas Ebert veröffentlicht:

 

Palmedo H, H. Bender, H. Urbach, I. Schmidt-Wolf, A. Matthies, A. Joe, J. Bucerius, J. Risse, H.-JBiersack,
H. Pels. Primary diagnosis and therapeutic monitoring of primary central nervous system lymphoma with FDG-PET in immunocompetent patients: correlation with MRI and clinical followup. Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):164-8.

Palmedo H, Bucerius J, Joe A, Strunk H, Hortling N, Meyka S, Roedel R, Wolff M, Wardelmann, Biersack HJ, Jaeger UE. Intergrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. J Nucl Med 2006;47:616-624.

Heinicke Th, Wardelmann E, Sauerbruch T, Tschampa H, Glasmacher A, Palmedo H. Very early detection of response to Imatinib Mesylate therapy of gastrointestinal stroma tumours using F-18 FDG positron emission tomography. Anticancer Res 2005;25:4591-4

Strunk H, Bucerius J, Jaeger U, Joe A, Flacke S, Reinhardt M, Hortling N, Palmedo H. Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy. Rofo. 2005 Sep;177(9):1235-41

Grünwald F, Schomburg A, Bender H, Klemm E, Menzel C, Bultmann T, Palmedo H, Ruhlmann J, Kozak B, Biersack HJ. Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow up of differentiated thyroid cancer. Eur J Nucl Med 1996 23:312-19.

Matthies A, Ezziddin S, Ulrich EM, Palmedo H, Biersack HJ, Bender H, Guhlke S. Imaging of prostate cancer metastases with F-18 Fluoroacetate using PET-CT. Eur J Nucl Med Mol Imaging 2004 31:797

Rodel R, Straehler-Pohl HJ, Palmedo H, Reichmann K, Jaeger U, Reinhardt MJ, Biersack HJ.
PET/CT imaging in head and neck tumors. Radiologe. 2004;44:1055-9.

von Mallek D, Backhaus B, Muller SC, Matthies A, Palmedo H, Jaeger U, Biersack HJ, Reinhardt M.
Technical Limits of PET/CT with 18FDG in Prostate Cancer.
Aktuelle Urol. 2006 May;37(3):218-21.

Biersack HJ, Palmedo H. Locally advanced breast cancer: is PET useful for monitoring primary chemotherapy? J Nucl Med. 2003 Nov; 44(11): 1815-7

Biersack HJ, Bender H, Palmedo H. FDG-PET in monitoring therapy of breast cancer. Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:112-7

Palmedo H. PET und PET-CT – Stellenwert beim Mammakarzinom. Der Nuklearmediziner 2004;27:295-303

P. Willkomm, H. Palmedo, M. Bangard, J. Ruhlmann, F. Grünwald, R. An. Mammakarzinom. In: J. Ruhlmann, P. Oehr, H.J. Biersack (Hrsg). PET in der Onkologie. Grundlagen und klinische Anwendungen. 1998 Springer- Verlag, 106-114

H. Bender, H. Palmedo, H.J. Biersack, A. Schomburg. Breast imaging with positron emission tomography. In: R. Taillefer, I. Khalkhali, A.D. Waxman, H.J. Biersack (eds.) radionuclide imaging of the breast. Marcel Dekker, New York 1998, 147-176

F. Grünwald, HJ Biersack, E Klemm, C Menzel, H. Bender , T Bultmann, A Schomburg, J Ruhlmann, H Palmedo. FDG-PET, J-131 and MIBI scintigraphy in the follow-up of differentiated thyroid cancer. In: Radioactive isotopes in clinical medicine and research XXII ed. by H Bergmann, A Kroiss, H Sinzinger
Birkhäuser-Verlag Basel/Switzerland 1997, S. 63-68.

H. Bender, H. Palmedo. Normal findings. IN: H. Bender, H. Palmedo, HJ. Biersack, PE. Valk (eds.) atlas of clinical PET in oncology. Springer, Berlin 2000, 11-19

JH. Risse, H. Palmedo, H. Bender. Malignant Melanoma. IN: H. Bender, H. Palmedo, HJ. Biersack, PE. Valk (eds.) atlas of clinical PET in oncology. Springer, Berlin 2000, 37-49

H. Palmedo. Breast cancer. IN: H. Bender, H. Palmedo, HJ. Biersack, PE. Valk (eds.) atlas of clinical PET in oncology. Springer, Berlin 2000, 95-109

H. Bender, H. Palmedo. Gynecological tumors. IN: H. Bender, H. Palmedo, HJ. Biersack, PE. Valk (eds.) atlas of clinical PET in oncology. Springer, Berlin 2000, 171-177

Biersack HHJ, Palmedo H, Kälicke T, et al. FDG-PET in infectious bone disease and spondylodiscitis. S. 99-102. In Radiopharmaceuticals for inflammation and infection. Ed. Limouris G, Biersack HJ, Shukla SK.
Mediterra-Publishers, Athens 2001.

H. Bender, H. Palmedo, HJ. Biersack, PE. Valk (eds.). Atlas of clinical PET in oncology. Springer, Berlin 2000.

Kinetics of 14(R,S)-Fluorine-18-Fluoro-6-Thia-Heptadecanoic Acid in Normal Human Hearts at Rest, During Exercise and After Dipyridamole Injection
Andreas Ebert, Hans Herzog, Gerhard L. Stöcklin, Michael M. Henrich, Timothy R. DeGrado, Heinz H. Coenen and Ludwig E. Feinendegen
J Nucl Med 1994; 35:51-56

Automatic three-segment, MR-based attenuation-correction for whole body PET/MR-data.
Schulz V, Torres-Espallardo I, Renisch S, Hu Z, Ojha , Börnert P, Perlmuh M, Niendorf T, Schaefer WM, Brockmann H, Krohn T, Buhl A, Günther RW, Mottaghy FM, Krombach GA.
Eur J Nucl Med Mol Imaging 2011 Jan; 38(1): 138-52.

Splenic infarction mimicking a necrotizing metastasis of malignant melanoma on F-18-FDG-PET/CT
Ahmadzadehfar H., Brockmann H., Schmiedel A, Biersack HJ, Ezziddin S.
Clin Nucl Med 2008 Aug; 33(8): 571-2

 

FEEDBACK
PRAXISINFO